Want to join the conversation?
Biotechnology company $AMGN said the European Commission (EC) has approved the marketing authorization for Kyprolis to include use in combination with dexamethasone for adults with multiple myeloma, an incurable blood cancer, who have received at least one prior therapy.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.